Ticker Details
AtriCure, Inc. AtriCure Inc is a medical device company. It develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, scars in cardiac, heart, and tissue. It generates revenue by selling disposable surgical devices.
IPO Date:	August 5, 2005
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$1.62B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.45 | 2.10%
Avg Daily Range (30 D):	$0.88 | 2.35%
Avg Daily Range (90 D):	$0.81 | 2.19%

Institutional Daily Volume
Avg Daily Volume:	.18M
Avg Daily Volume (30 D):	.65M
Avg Daily Volume (90 D):	.49M

Trade Size
Avg Trade Size (Sh.):	70
Avg Trade Size (Sh.) (30 D):	54
Avg Trade Size (Sh.) (90 D):	49

Institutional Trades
Total Institutional Trades:	3,349
Avg Institutional Trade:	$1.8M
Avg Institutional Trade (30 D):	$2M
Avg Institutional Trade (90 D):	$1.94M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.07M
Avg Closing Trade (30 D):	$3.21M
Avg Closing Trade (90 D):	$2.87M
Avg Closing Volume:	53.88K

News

Nov 29, 2025 @ 9:24 PM Is AtriCure Stock a Buy or Sell After a Director D... Source: Robert Izquierdo

May 14, 2025 @ 6:00 PM Questex’s Fierce Healthcare Announces 2025 ... Source: Questex'S Fierce Healthcare

Jul 23, 2024 @ 6:08 PM AtriCure gains China's nod for heart surgery devic... Source: Natashya Angelica

May 2, 2024 @ 12:01 PM Cracking The Code: Understanding Analyst Reviews F... Source: Benzinga Insights

May 2, 2024 @ 12:00 AM Compared to Estimates, AtriCure (ATRC) Q1 Earnings... Source: Zacks Equity Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.24	$.04	$-.24
Diluted EPS	$-.24	$.04	$-.24
Revenue	$534.53M	$140.5M	$534.53M
Gross Profit	$400.78M	$105.34M	$400.78M
Net Income / Loss	$-11.45M	$1.76M	$-11.45M
Operating Income / Loss	$-9.45M	$2.49M	$-9.45M
Cost of Revenue	$133.75M	$35.16M	$133.75M
Net Cash Flow	$44.71M	$19.56M	$44.71M
PE Ratio